StockData
Medicus Pharma Ltd. logo

Medicus Pharma Ltd. (MDCX) stock

MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.52−0.17 (-10.06%)

Close on Nov 17, 2026Market cap $2.81MP/E –Yield –

Medicus Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Medicus Pharma's operating income for the twelve months ending Sep 30, 2026 was -$42.33M. For fiscal 2025 it was -$34.36M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$34.36M–
FY2024Dec 31, 2024-$11.18M–
FY2023Dec 31, 2023-$4.73M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$14.46M–
Q2 FY2026Jun 30, 2026-$11.48M–
Q1 FY2026Mar 31, 2026-$8.60M–
Q4 FY2025Dec 31, 2025-$7.79M–
Q3 FY2025Sep 30, 2025-$15.43M–
Q2 FY2025Jun 30, 2025-$6.02M–
Q1 FY2025Mar 31, 2025-$5.13M–
Q4 FY2024Dec 31, 2024-$3.59M–
Q3 FY2024Sep 30, 2024-$2.33M–
Q2 FY2024Jun 30, 2024-$3.55M–
Q1 FY2024Mar 31, 2024-$1.71M–

More Medicus Pharma figures

See a number that looks wrong?